#1 Clinical Trials Search in Europe

Pantoprazole

Pantoprazole, a proton pump inhibitor, has been extensively studied in clinical trials for various conditions, primarily related to gastric acid suppression. This article examines the use of pantoprazole in clinical research, focusing on its efficacy, safety, and potential applications in different patient populations.

Table of Contents

What is Pantoprazole?

Pantoprazole is a medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It is commonly known by brand names such as Protonix[1], Pantoloc[2], and Protonix[3]. This medication is widely used to treat various conditions related to excessive stomach acid production.

What Conditions Does Pantoprazole Treat?

Pantoprazole is primarily used to treat the following conditions:

  • Gastroesophageal Reflux Disease (GERD): This is a condition where stomach acid frequently flows back into the esophagus, causing symptoms like heartburn and difficulty swallowing[4].
  • Erosive Esophagitis: This is a severe form of GERD where stomach acid causes damage to the lining of the esophagus[5].
  • Zollinger-Ellison Syndrome: A rare condition that causes tumors in the pancreas or small intestine, leading to excessive stomach acid production[3].

How Does Pantoprazole Work?

Pantoprazole works by reducing the amount of acid produced in the stomach. It does this by blocking an enzyme called H+/K+ ATPase, also known as the proton pump, which is responsible for the final step of acid production in the stomach[6]. By inhibiting this enzyme, pantoprazole effectively decreases stomach acid levels, providing relief from symptoms associated with excess acid and allowing damaged tissues to heal.

How is Pantoprazole Administered?

Pantoprazole can be administered in several ways:

  • Oral tablets: These are delayed-release tablets that are taken by mouth[1].
  • Intravenous (IV) injection: In some cases, particularly for hospitalized patients or those unable to take oral medications, pantoprazole can be given through an IV[4].
  • Oral suspension: For children or adults who have difficulty swallowing tablets, pantoprazole may be available as a liquid suspension[7].

Dosage Information

The dosage of pantoprazole varies depending on the condition being treated, the patient’s age, and other factors. Some common dosages include:

  • For adults with GERD: 40 mg once daily for up to 8 weeks[1].
  • For children (aged 5 years and older) with GERD: Dosage is based on weight, typically ranging from 20 mg to 40 mg once daily[4].
  • For severe conditions or hospitalized patients: Higher doses may be used, sometimes administered intravenously[3].

It’s important to note that dosage should always be determined by a healthcare professional based on individual patient needs.

Effectiveness of Pantoprazole

Studies have shown that pantoprazole is effective in treating various acid-related conditions. For example, in patients with erosive esophagitis, pantoprazole has been shown to promote healing and provide symptom relief[3]. It has also been found to be effective in maintaining healing in patients who have recovered from erosive esophagitis[5].

Potential Side Effects

While pantoprazole is generally well-tolerated, like all medications, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Nausea
  • Diarrhea
  • Stomach pain
  • Dizziness

More serious side effects are rare but can occur. These may include severe allergic reactions, liver problems, or an increased risk of certain infections. It’s important to discuss any side effects with your healthcare provider[4].

Use in Special Populations

Pantoprazole has been studied in various populations:

  • Children and adolescents: Pantoprazole has been studied in children as young as 1 year old for the treatment of GERD[4].
  • Obese patients: Research has been conducted to understand how obesity might affect the way the body processes pantoprazole[7].
  • Patients with heart failure: Studies have looked at the potential effects of pantoprazole on heart function in patients with congestive heart failure[6].

Drug Interactions

Pantoprazole can interact with other medications. For example, it may affect the absorption of certain drugs that require stomach acid for proper absorption. It’s important to inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements[2].

Ongoing Research

Research on pantoprazole is ongoing, with studies looking at various aspects of its use:

  • Its effects on the levels of other medications in the body[2].
  • The impact of genetic factors on how individuals respond to pantoprazole[7].
  • Its use in different patient populations and for various conditions[5].

These ongoing studies help to further our understanding of pantoprazole and may lead to improved treatment strategies in the future.

Aspect Details
Primary Uses Treatment of GERD, erosive esophagitis
Dosage Forms Oral tablets, intravenous infusions, delayed-release formulations
Common Dosage 40 mg daily (oral or IV)
Study Populations Adults, children, adolescents, obese patients
Key Outcomes Measured Symptom relief, healing rates, pharmacokinetics, sleep quality
Special Considerations Effects of obesity, age, and genetic factors on drug metabolism
Safety Profile Generally well-tolerated, ongoing studies for long-term effects
Emerging Research Areas Impact on heart function, interactions with psychiatric medications

FAQ

  • What is pantoprazole and how does it work? Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production. It works by blocking the enzyme in the wall of the stomach that produces acid, helping to treat conditions like gastroesophageal reflux disease (GERD) and erosive esophagitis.
  • What conditions are being studied using pantoprazole in clinical trials? Clinical trials are investigating pantoprazole for various conditions, including gastroesophageal reflux disease (GERD), erosive esophagitis, and its potential effects on heart function in patients with congestive heart failure. Some studies also explore its impact on sleep quality in GERD patients.
  • How is pantoprazole administered in clinical trials? Pantoprazole is administered in various forms in clinical trials, including oral tablets (often 40 mg), intravenous infusions, and delayed-release formulations. The dosage and method of administration depend on the specific study and condition being treated.
  • Are there any special considerations for pantoprazole use in certain populations? Yes, some trials are investigating pantoprazole use in specific populations, such as children and adolescents with GERD, and obese patients. These studies aim to understand how factors like age, body weight, and metabolism affect the drug's effectiveness and safety.
  • What are some of the outcomes being measured in pantoprazole clinical trials? Clinical trials measure various outcomes, including changes in acid reflux symptoms, healing of erosive esophagitis, pharmacokinetic parameters (like drug concentration in the blood), effects on sleep quality, and potential impacts on other medications. Some studies also assess bioequivalence between different formulations of pantoprazole.

Ongoing Clinical Trials on Pantoprazole

  • Study on Ropivacaine and Lidocaine for Reducing Pain After Tonsil Removal in Patients with Chronic Tonsillitis

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria

  • Study on Adding Diclofenac to PD-1 Inhibitor Therapy for Patients with Metastatic Melanoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on How Pantoprazole Affects the Absorption of Mycophenolate Mofetil in Post-Transplant Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Aspirin and Pantoprazole for Reducing Heart Attack Risk in Hospitalized Pneumonia Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Poland Spain

Glossary

  • Proton Pump Inhibitor (PPI): A class of medications that reduce stomach acid production by blocking the enzyme responsible for acid secretion.
  • Gastroesophageal Reflux Disease (GERD): A digestive disorder that occurs when stomach acid frequently flows back into the esophagus, causing symptoms like heartburn and acid reflux.
  • Erosive Esophagitis: Inflammation and damage to the lining of the esophagus, often caused by chronic acid reflux.
  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and to have comparable bioavailability.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • CYP2C19: An enzyme in the liver that plays a role in metabolizing certain drugs, including pantoprazole.
  • Delayed Release: A formulation designed to release the active ingredient of a drug at a time or in a location different from immediately after administration.
  • Intravenous (IV) Infusion: The administration of a drug directly into a vein over a period of time.
  • Fasting Condition: A state where a person has not eaten for a specified period, usually at least 8-10 hours.
  • Fed Condition: A state where a person has recently eaten a meal, often used in drug studies to assess how food affects medication absorption.

References

  1. https://clinicaltrials.gov/study/NCT01654718
  2. https://clinicaltrials.gov/study/NCT02213887
  3. https://clinicaltrials.gov/study/NCT00133770
  4. https://clinicaltrials.gov/study/NCT02401035
  5. https://clinicaltrials.gov/study/NCT04821310
  6. https://clinicaltrials.gov/study/NCT00699361
  7. https://clinicaltrials.gov/study/NCT01887743